Evidence map›Paper›PMID 40655657›Full record

ArticleJournal of pharmacy & bioallied sciences2025

Ahmed Ismail Nagy, Mohammad Khursheed Alam, Shahad Abdullah Alanazi, Samer Abdullah Alanazi, Shouq Hussain Albuhairan, Nor Farid Bin Mohd Noor

Abstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ahmed Ismail NagyDepartment of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Mohammad Khursheed AlamPreventive Dentistry Department, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Shahad Abdullah AlanaziDepartment of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Samer Abdullah AlanaziDepartment of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Shouq Hussain AlbuhairanDepartment of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka, Saudi Arabia.
Nor Farid Bin Mohd NoorDepartment of Anatomy and Physiology, Faculty of Medicine, Universiti Sultan Zainal Abidin (UniSZA), Medical Campus, Jalan Sultan Mahmud, 20400 Kuala Terengganu, Terengganu Darul Iman, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alcohol use and smoking have been shown to be substantial risk factors for oral cancer, a serious worldwide health problem. The growth of oral cancer cells is thought to be influenced by certain lifestyle choices. Materials and Methods: Oral squamous cell carcinoma, or SCC-25, cell lines were used in a carefully monitored Results: Exposure to ethanol and CSE dramatically decreased cell viability in a way that was dependent on both time and dosage. After 10 μg/mL, 20 μg/mL, and 50 μg/mL, the smoking group's proliferation reduced by 25%, 35%, and 50% after 72 hours, respectively. At 1%, 5%, and 10% ethanol concentrations, the alcohol group also showed reductions of 20%, 30%, and 45%, respectively. With a 60% decrease in proliferation, the combined exposure group showed the strongest inhibition, suggesting a synergistic impact. Statistical significance was noted for every experimental group ( Conclusion: Both alcohol exposure and smoking significantly reduce the growth of oral cancer cells, and their combined effects are synergistic. These results highlight how important lifestyle changes are for managing and preventing oral cancer.

Indexed as

Alcoholcell proliferationin vitro studyMTT assayoral cancerSCC-25 cellssmoking

Identifiers

PMID40655657
PMCPMC12244733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.